Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report

Treatment outcomes for inoperable advanced non-small cell lung cancer have improved in recent years. However, information on coexisting haematological tumours is lacking. The present patient was a 65-year-old woman with stage IVA lung adenocarcinoma. The patient was administered a combination of pla...

Full description

Saved in:
Bibliographic Details
Published in:Oncology letters 2025-01, Vol.29 (1), Article 31
Main Authors: Nagasue, Kazunori, Kida, Ryotaro, Shigaki, Ryota, Nitanai, Kiichi, Yagita, Akari, Yanada, Hiraku, Umekage, Yasuhiro, Mori, Chie, Minami, Yoshinori, Funayama, Takuya, Yamamoto, Masayo, Tanino, Mishie, Yoshida, Ryohei, Sasaki, Takaaki
Format: Article
Language:English
Subjects:
Biopsy
Blood
Bone marrow
Cancer therapies
Case Report
Case reports
Chemotherapy
Chronic illnesses
Cytotoxicity
Kinases
Leukemia
Lung cancer
Lymphatic system
Metastasis
Mutation
Myelodysplastic syndromes
Radiation
Steroids
Tomography
Tumors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment outcomes for inoperable advanced non-small cell lung cancer have improved in recent years. However, information on coexisting haematological tumours is lacking. The present patient was a 65-year-old woman with stage IVA lung adenocarcinoma. The patient was administered a combination of platinum therapy and immune checkpoint inhibitors. The patient was subsequently diagnosed with chronic myeloid leukaemia (CML) following leukocytosis. Carboplatin and pemetrexed combination therapy resulted in shrinkage of lung cancer. Improvements in peripheral blood leukocyte counts and bone marrow findings were observed. These results suggested that the treatment of lung cancer may control the course of CML.
ISSN:1792-1074
1792-1082
DOI:10.3892/ol.2024.14777